Virax Biolabs Group Limited
VRAX · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,067 | -$6,739 | -$5,457 | -$1,709 |
| Dep. & Amort. | $343 | $103 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $365 | $1,012 | $1,735 | $290 |
| Change in WC | $626 | -$1,120 | -$216 | $644 |
| Other Non-Cash | $169 | $497 | -$261 | -$32 |
| Operating Cash Flow | -$4,564 | -$6,247 | -$4,180 | -$809 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$604 | -$952 | -$178 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$212 | -$178 | $0 |
| Investing Cash Flow | -$604 | -$1,164 | -$178 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$108 | -$206 | $146 | $100 |
| Stock Issued | $5,128 | $0 | $13,654 | $520 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $787 | $1,854 | -$112 | $194 |
| Financing Cash Flow | $5,807 | $1,648 | $13,689 | $813 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $640 | -$5,763 | $9,331 | $4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,589 | $9,353 | $22 | $18 |
| End Cash | $4,229 | $3,589 | $9,353 | $22 |
| Free Cash Flow | -$5,167 | -$7,411 | -$4,358 | -$809 |